View the Latest: Medicare Part D
Filter
-
-
Understanding the Health Care Provisions in the Inflation Reduction Act
Event Date:EventOn Thursday, August 11, a panel of KFF experts held a web briefing to explain the provisions in the Inflation Reduction Act and how they would affect people and federal health spending.
-
What Are the Prescription Drug Provisions in the Inflation Reduction Act?
FeatureThis slideshow explains the prescription drug provisions proposed in the Inflation Reduction Act as passed by the Senate
-
How Will the Prescription Drug Provisions in the Inflation Reduction Act Affect Medicare Beneficiaries?
Issue BriefThe brief provides a quick explainer of the prescription drug provisions in the Inflation Reduction Act signed into law on August 16, 2022 and presents new estimates on how many Medicare beneficiaries could be helped by those provisions.
-
Most Antiretrovirals Covered by Medicare Part D (as of 2017) Are Brand-Name, Single Source Medications
FeatureMost ARVs Covered by Medicare Part D are Brand Single Source Download
-
Number of Medicare Stand-alone Prescription Drug Plans (PDPs)
State Health Facts Indicator -
Weighted Average Monthly Premium for Medicare Part D Stand-alone Prescription Drug Plans
State Health Facts Indicator -
What to Know About the Medicare Open Enrollment Period and Medicare Coverage Options
Issue BriefEach year, Medicare beneficiaries have an opportunity to make changes to how they receive their Medicare coverage during the nearly 8-week annual open enrollment period. This brief answers key questions about the Medicare open enrollment period and Medicare coverage options.
-
5 Questions About the Idea of Default Enrollment into Medicare Advantage Plans
Issue BriefThis brief considers how default enrollment into Medicare Advantage might work, potential challenges with this approach, and implications for beneficiaries, insurers, providers, agents and brokers, and the federal budget.
-
Medicare Part D Premiums Are Increasing for Many But Not All Stand-Alone Plans in 2025, Reflecting Effects of New Premium Stabilization Demonstration
Policy WatchThis policy watch examines monthly premiums for Medicare Part D stand-alone drug plans in 2025, as changes to the Part D benefit are being implemented in 2025, including a new $2,000 cap on out-of-pocket drug spending.